参考文献アーカイブ：BALB/cAJcl-nu/nu

2008

• Sugae S, Suzuki A, Takahashi N, Minamimoto R, Cheng C, Theeraladanon C, Endo I, Togo S, Inoue T, Shimada H.
  Fluorine-18-labeled 5-fluorouracil is a useful radiotracer for differentiation of malignant tumors from inflammatory lesions.
  Ann Nucl Med. 2008 Jan;22(1):65-72. doi: 10.1007/s12149-007-0081-4.

2013

• Hino-Shishikura A, Suzuki A, Minamimoto R, Shizukuishi K, Oka T, Tateishi U, Sugae S, Ichikawa Y, Horiuchi C, Inoue T.
  Biodistribution and radiation dosimetry of [¹⁸F]-5-fluorouracil.
  Appl Radiat Isot. 2013 May;75:11-7. doi: 10.1016/j.apradiso.2013.01.014. Epub 2013 Jan 20.

2023

• Matsumoto K, Sawano H, Otsubo M, Yui A.
  Comparison of the Effects of 3 Forms of Soluble Dietary Fiber on the Production of IgA in BALB/cAJcl and BALB/cAJcl-nu/nu Mice.
  J Nutr. 2023 May;153(5):1618-1626. doi: 10.1016/j.tjnut.2023.03.037. Epub 2023 Apr 1.

• Sorin S, Zhou Y, Thithuan K, Khawkhiaw K, Zeng F, Ruangpratyakul T, Chomphoo S, Seubwai W, Wongkham S, Saengboonmee C.
  High glucose enhances the aggressiveness of lung adenocarcinoma via activating epidermal growth factor receptor/signal transducer and activator of transcription 3 pathways.
  J Nutr Biochem. 2023 Sep;119:109399. doi: 10.1016/j.jnutbio.2023.109399. Epub 2023 Jun 2.

• Sato T, Kakei Y, Hasegawa T, Kashin M, Teraoka S, Yamaguchi A, Sasaki R, Akashi M.
  Gold Nanoparticles Enhance the Tumor Growth-Suppressing Effects of Cetuximab and Radiotherapy in Head and Neck Cancer In Vitro and In Vivo.
  Cancers (Basel). 2023 Dec 3;15(23):5697. doi: 10.3390/cancers15235697.

2024

• Mori M, Saito N, Shirado T, Wu Y, Asahi R, Yoshizumi K, Yamamoto Y, Zhang B, Yoshimura K.
  Human Adipose-Derived Endothelial Progenitor Cells Accelerate Epithelialization of Radiation Ulcers in Nude Mice.
  Plast Reconstr Surg. 2024 Mar 1;153(3):625-635. doi: 10.1097/PRS.0000000000010756. Epub 2023 May 24.

• Yamada K, Mukaimine A, Nakamura A, Kusakari Y, Pradipta AR, Chang TC, Tanaka K.
  Chemistry-driven translocation of glycosylated proteins in mice
  Nat Commun. 2024 Oct 2;15(1):7409. doi: 10.1038/s41467-024-51342-5. PMCID: PMC11446924

• Horiguchi M, Yoshihara K, Watanabe K, Tsurudome Y, Mizukami Y, Ushijima K.
  Circadian Rhythms of Clock Genes After Transplantation of Mesenchymal Stem Cells with Type 2 Diabetes Mellitus
  Int J Mol Sci. 2024 Dec 6;25(23):13145. doi: 10.3390/ijms252313145. PMCID: PMC11641841

• Jeeunngoi J, Senawong G, Jogloy S, Prompipak J, Samankul A, Utaiwat S, Woranam K, Sripa B, Senawong T.
  Anticancer Potential of Valencia Peanut (Arachis hypogaea L.) Skin Extract against Cervical Cancer Cells In Vitro and in Nude Mouse Xenograft Models
  Foods. 2024 Jul 26;13(15):2354. doi: 10.3390/foods13152354. PMCID: PMC11312182

• Dash S, Ueda T, Komuro A, Honda M, Sugisawa R, Okada H.
  Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer
  Cell Death Dis. 2024 Feb 12;15(2):131. doi: 10.1038/s41419-024-06531-x. PMCID: PMC10861559

2025

• Shan AP, Hlaing KS, Leelahavanichkul A, Amornphimoltham P.
  Efficacy of metformin and verteporfin treatment alone or in combination in a murine head and neck cancer xenograft model.
  Eur J Oral Sci. 2025 Feb;133(1):e13034. doi: 10.1111/eos.13034. Epub 2025 Jan 8. PMID: 39780329

• Owaki R, Hosoya K, Deguchi T, Konnai S, Maekawa N, Okagawa T, Yasui H, Kim S, Sunaga T, Okumura M.
  Enhancement of radio-sensitivity by inhibition of Janus kinase signaling with oclacitinib in canine tumor cell lines
  Mol Ther Oncol. 2025 Feb 3;33(1):200946. doi: 10.1016/j.omton.2025.200946. eCollection 2025 Mar 20. PMID: 40051504

• Horiguchi M, Yoshihara K, Mizukami Y, Watanabe K, Tsurudome Y, Ushijima K.
  The Diurnal Variation in Mitochondrial Gene in Human Type 2 Diabetic Mesenchymal Stem Cell Grafts
  Int J Mol Sci. 2025 Jan 16;26(2):719. doi: 10.3390/ijms26020719. PMCID: PMC11765740

• Yamamoto M, Koyanagi K, Nishi T, Kazuno A, Shoji Y, Ninomiya Y, Kanamori K, Tajima K, Nakashima R, Mori M.
  Effects of β-hydroxy-β-methylbutyrate on skeletal muscle loss in a mouse model of esophageal squamous cell carcinoma
  Ann Transl Med. 2025 Dec 19;13(6):71. doi: 10.21037/atm-25-126. PMCID: PMC12771045

• Hirasawa S, Murakami K, Kano M, Endo S, Toyozumi T, Matsumoto Y, Otsuka R, Sekino N, Shiraishi T, Ryuzaki T, Kinoshita K, Sasaki T, Matsubara H.
  MSC and HUVEC co-cultured fillers overcome intractable fistula in a new mouse model
  PLoS One. 2025 Aug 21;20(8):e0330478. doi: 10.1371/journal.pone.0330478. PMCID: PMC12370064

• Adachi Y, Miyake K, Ohira K, Satoh S, Masuhiro K, Edahiro R, Shirai Y, Naito M, Naito Y, Shiroyama T, Koyama S, Hirata H, Iwahori K, Nagatomo I, Takeda Y, Kumanogoh A.
  Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44–targeting antibody–photoabsorber conjugates
  EBioMedicine. 2025 Jan 22;112:105566. doi: 10.1016/j.ebiom.2025.105566. PMCID: PMC11795636

• Namwan N, Senawong G, Phaosiri C, Kumboonma P, Somsakeesit LO, Sangchang P, Senawong T.
  Curcumin Derivative CU4c Exhibits HDAC-Inhibitory and Anticancer Activities Against Human Lung Cancer Cells In Vitro and in Mouse Xenograft Models
  Pharmaceuticals (Basel). 2025 Jun 26;18(7):960. doi: 10.3390/ph18070960. PMCID: PMC12297909

2026

• Kasuga H, Kataoka Y, Yamamoto F, Miyamoto R, Tsuji S, Suzuki T, Mizuarai S.
  TAS3351 is a brain penetrable EGFR-TKI that overcomes T790M and C797S resistant mutations
  Commun Med (Lond). 2026 Mar 25;6(1):284. doi: 10.1038/s43856-026-01546-1. PMCID: PMC13181001